DexCom Inc (DXCM) Stock Forecast
US · Healthcare
Current price
$68.65
Market cap
$26.49B
Mean price target
$85.24
Implied upside
24.2%
Key takeaways
- Analysts rate DexCom Inc a “Strong Buy”, with a mean price target of $85.24 — about 24.2% upside from the current $68.65, based on 25 analysts.
- DXCM is trading in the middle of its 52-week range, at 41% of the $54.11–$89.98 band.
Analyst consensus
| Consensus rating | Strong Buy |
|---|---|
| Number of analysts | 25 |
| Mean target | $85.24 |
| High target | $112.00 |
| Low target | $65.00 |
| Rating split (SB / B / H / S / SS) | 4 / 20 / 2 / 0 / 1 |
Price & trading
| Current price | $68.65 |
|---|---|
| Previous close | $69.73 |
| 52-week high | $89.98 |
| 52-week low | $54.11 |
| 50-day average | $66.90 |
| Beta | 1.44 |
See the full DXCM breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current DexCom Inc (DXCM) share price?
- DexCom Inc last traded at $68.65 with a market capitalisation of about $26.5B.
- What is the analyst price target for DXCM?
- The mean analyst price target for DexCom Inc is $85.24, roughly 24.2% above the latest price. The current consensus rating is “Strong Buy”.
- Where can I see DexCom Inc's full financial metrics?
- Luminoso tracks DXCM's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.